Literature DB >> 14676931

[Attempted control of mucocutaneous leishmaniasis through treatment of diseased dogs].

P A Sessa1, A Falqueto, J B Varejão.   

Abstract

An attempt was made to control cutaneous leishmaniasis in the municipality of Santa Leopoldina, Espírito Santo State, Brazil, by treating infected dogs. Another area in the municipality of Afonso Cláudio, which is ecologically similar, served as the control area, and dogs were left untreated there. In an initial survey, 34/141 inhabitants of the first area had positive leishmanin tests and 8/26 dogs had cutaneous leishmaniasis, while in the second area 37/127 individuals had positive leishmanin tests and 7/44 dogs were infected. After treatment of the sick dogs in the first area the populations of both areas were periodically examined for new infections. More new human infections were observed in the control area, but the difference was not statistically significant.

Entities:  

Year:  2003        PMID: 14676931     DOI: 10.1590/s0102-311x1994000400005

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  2 in total

1.  Different susceptibilities of Leishmania spp. promastigotes to the Annona muricata acetogenins annonacinone and corossolone, and the Platymiscium floribundum coumarin scoparone.

Authors:  Nadja Soares Vila-Nova; Selene Maia de Morais; Maria José Cajazeiras Falcão; Terezinha Thaize Negreiros Alcantara; Pablito Augusto Travassos Ferreira; Eveline Solon Barreira Cavalcanti; Icaro Gusmão Pinto Vieira; Cláudio Cabral Campello; Mary Wilson
Journal:  Exp Parasitol       Date:  2012-12-08       Impact factor: 2.011

2.  Environmental Niche Modelling of Phlebotomine Sand Flies and Cutaneous Leishmaniasis Identifies Lutzomyia intermedia as the Main Vector Species in Southeastern Brazil.

Authors:  Viviane Coutinho Meneguzzi; Claudiney Biral Dos Santos; Gustavo Rocha Leite; Blima Fux; Aloísio Falqueto
Journal:  PLoS One       Date:  2016-10-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.